Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis : acute myeloid leukemia - Ronnacker, Julian; Muller, Philippe J.; Mikesch, Jan-Henrik; Zukunft, Sven; Weinbergerová, Barbora; Šrámek, Jiří; Valka, Jan; Novak, Jan; Zak, Pavel; Szotkowski, Tomas; Koristek, Zdenek; Krekeler, Carolin; et al. (Leukemia, 2025)
Gesehen am 16.09.2025